| | 305820-75-1 Basic information More.. |
| Product Name: | PD 173952 | | Synonyms: | PD 173952;6-(2,6-dichlorophenyl)-8-methyl-2-(4-morpholin-4-ylanilino)pyrido[2,3-d]pyrimidin-7-one;6-(2,6-Dichlorophenyl)-8-Methyl-2-[[4-(4-Morpholinyl)phenyl]aMino]pyrido[2,3-d]pyriMidin-7(8H)-one;6-(2,6-Dichloro-phenyl)-8-Methyl-2-(4-Morpholin-4-yl-phenylaMino)-8H-pyrido[2,3-d]pyriMidin-7-one;Pyrido[2,3-d]pyrimidin-7(8H)-one, 6-(2,6-dichlorophenyl)-8-methyl-2-[[4-(4-morpholinyl)phenyl]amino]-;6-(2,6-Dichlorophenyl)-8-methyl-2-((4-morpholinophenyl)amino)pyrido[2,3-d]pyrimidin-7(8H)-one | | CAS: | 305820-75-1 | | MF: | C24H21Cl2N5O2 | | MW: | 482.36 | | EINECS: | | | Mol File: | 305820-75-1.mol |  |
Use
As a Bcr-Abl tyrosine kinase inhibitor, 6-(2,6-dichlorophenyl)-8-methyl-2-(4-morpholin-4-ylanilino)pyrido[2,3-d]pyrimidin-7-one can be used in treatment research for chronic myelegenous leukemia (CML).
|
|
305820-75-1
Recommend Suppliers |
|